Literature DB >> 23266459

Use of HIT for adverse event reporting in nursing homes: barriers and facilitators.

Laura M Wagner1, Nicholas G Castle, Steven M Handler.   

Abstract

BACKGROUND &
OBJECTIVE: Approximately 8 million adverse events occur annually in nursing homes (NHs). The focus of this research is to determine barriers and health information technology (HIT)-related facilitators to adverse event reporting among U.S. NHs.
METHODS: Surveys were returned by 399 nursing home administrators using a mailed survey approach. Respondents were asked to report on their adverse event reporting processes focusing on barriers and role of HIT facilitators.
RESULTS: About 15% of NHs had computerized entry by the nurse on the unit and almost 18% used no computer technology to track, monitor, or maintain adverse event data. One-third of nursing directors conducted data analysis "by-hand." NHs without HIT were more likely to not be accredited (p = 0.04) and not part of a chain/corporation (p = 0.03). Two of the top three barriers focused on fears of reporting as a barrier.
CONCLUSIONS: This study found numerous barriers and few HIT-related facilitators to assist with adverse event reporting. Improvements in facilitating adverse event reporting through the use of HIT approaches may be warranted.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23266459     DOI: 10.1016/j.gerinurse.2012.10.003

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.361


  2 in total

1.  Reliability and validity of the Chinese version of reporting of clinical adverse events scale (C-RoCAES).

Authors:  Xiao Sun; Yan Shi; Shuying Zhang; Meimei Tian; Yafen Mao; Qian Wu; Xiaoping Zhu; Meifang Gong
Journal:  Int J Clin Exp Med       Date:  2014-10-15

2.  Impact of infection preventionists on Centers for Medicare and Medicaid quality measures in Maryland nursing homes.

Authors:  Laura M Wagner; Brenda J Roup; Nicholas G Castle
Journal:  Am J Infect Control       Date:  2014-01       Impact factor: 2.918

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.